You searched for "blink"

4714 results found

AI-Based devices in national screening programmes: barriers and challenges

Diabetic retinopathy (DR) may have long-term complications and is recorded as a leading cause of blindness. National DR screening programmes have effectively reduced severe visual loss by timely detection and subsequent treatment of sight-threatening proliferative DR and diabetic macular oedema....

Does delayed strabismus surgery have an association with psychiatric diagnoses in children?

The authors present a retrospective cohort study with the aim of assessing the association between strabismus surgery in early childhood and psychiatric diagnosis incidence. An international healthcare records platform was utilised to access electronic medical records from 92 healthcare organisation....

Climate Change and Eye Disease: Eye Health and Blindness in a Hostile Environment

Climate Change and Eye Disease: Eye Health and Blindness in a Hostile Environment by Scott Fraser offers a thorough examination of how climate change is impacting ocular health. The book explores a variety of eye conditions that are being influenced...

Case series of toxic anterior segment syndrome

Herein we report two cases of toxic anterior segment syndrome (TASS) following uneventful cataract surgery. Both patients presented 24 hours after their uneventful operations with painless blurred vision in the operated eye. The inflammatory reaction was controlled successfully with an...

Glaucoma: 30 years on

Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Choosing a subspecialty

It is quite worrying how many registrars reach the final years of training without choosing a subspecialty. Sometimes this is because they love everything and cannot countenance giving any of it up, but more commonly this is due to various...

A message from the editors

Right now you may be self-isolating, self-learning about Covid-19 and / or selflessly looking after family, friends or folk next door who need supplies, meds or general cheering up, albeit at a distance. Some of us might be redeployed, frantically...

Dr Peter Davey joins the SEE Summit

The Association of British Dispensing Opticians (ABDO) has announced another speaker for the SEE Summit, Dr Peter Davey, Chief Sustainability Officer’s Clinical Fellow 2022–2023, working with NHS England on a variety of projects including net zero eyecare.

ABDO announces dates for the ABDO Clinical Conference

The Association of British Dispensing Opticians (ABDO) has announced the dates for its second clinical conference. The ABDO clinical conference will take place on Sunday 6 and Monday 7 October at the ABDO National Resource Centre, Birmingham, providing two opportunities for members to attend.

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...